Moderna Inc (MEX:MRNA)
MXN 2402 -118.54 (-4.7%) Market Cap: 930.10 Bil Enterprise Value: 806.05 Bil PE Ratio: 0 PB Ratio: 4.26 GF Score: 61/100

Moderna Inc CMV Interim Data Conference Call Transcript

Jan 10, 2020 / 01:00PM GMT
Release Date Price: MXN390 (+3.01%)
Operator

Good morning, and welcome to the Moderna CMV 7-month Interim Data Conference Call. (Operator Instructions) Please be advised that the call is being recorded.

At this time, I'd like to turn the call over to Lavina Talukdar, Head of Investor Relations at Moderna. Please proceed.

Lavina Talukdar
Moderna, Inc. - Head of IR

Thank you, Shannon. Good morning and happy new year, everyone. At today's conference call, we will review 7-month interim data from the company's Phase I CMV vaccine program. You can access the press release issued yesterday as well as the slides that we'll be reviewing by going to the Investors section of our website.

Speaking on the call today will be Stéphane Bancel, Chief Executive Officer; and Tal Zaks, Chief Medical Officer. Also present in the room is Lorence Kim, Chief Financial Officer.

Before we begin, I would like to remind you that this conference call will include forward-looking statements. Please see Slide 2 of the accompanying presentation and our SEC filings for important factors that could cause

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot